Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/24 17:26 | 6/24/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Wang Julia Aijun | E9 | O | CFO | 2 | S | -286 | 157.36 | 0 | -2 | 0 | 444 | D | ||||||||||||||
6/26/24 17:25 | 6/24/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Wang Lai | E9 | O | Global H | 2 | S.m | -538 | 158.06 | 0 | -3 | 0 | 1,797 | D | ||||||||||||||
6/26/24 17:24 | 6/24/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Wu Xiaobin | E9 | O | P,COO,GM | 2 | S.m | -738 | 156.66 | 0 | -5 | 0 | 1,243 | D | ||||||||||||||
6/26/24 17:22 | 6/24/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | 3 | S.m | -8,124 | 150.25 | 0 | -54 | 0 | 47,986 | D | ||||||||||||||
6/20/24 17:24 | 6/17/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | E9 | O | SVP,GC | 1 | S | -70 | 159.35 | 0 | 0 | 0 | 264 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |